From the makers of
Track & Manage All Of Your Investments
Try It Now!
New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
Valeant Pharmaceuticals International (VRX)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
30-JUN
2009
30-SEP
2009
31-DEC
2009
31-MAR
2010
30-JUN
2010
Total Revenue
225M
228M
238M
223M
254M
Cost of Revenue
52.6M
48.9M
46.7M
53.6M
59.2M
Gross Profit
172M
179M
192M
169M
-
Research & Development
51.9M
24.9M
38.2M
67.9M
39.6M
SG&A
57.5M
48.1M
45.7M
44.1M
56.0M
Amortization & Deprec
56.1M
76.5M
79.7M
73.7M
79.4M
Other Expenses
-12.4M
-33.2M
-30.8M
-33.4M
-32.6M
Total Operating Expenses
153M
116M
133M
152M
142M
Operating Income
12.2M
62.6M
58.4M
16.6M
-
Other Income
17.9M
298K
-1.43M
-789K
292K
EBIT
37.0M
63.2M
57.3M
16.0M
52.4M
Minority Interest
0
0
0
0
0
Interest Expense
4.70M
11.8M
10.1M
9.97M
10.6M
Income Before Taxes
32.3M
51.4M
47.2M
6.04M
41.8M
Income Taxes
4.30M
8.05M
-26.8M
9.23M
5.74M
Net Income from Continuing Ops
28.0M
43.3M
73.9M
-3.20M
36.1M
Income - Discontinued Ops
0
0
0
0
0
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
28.0M
43.3M
73.9M
-3.20M
36.1M
Preferred Dividends
0
0
0
0
0
Net Income to Common
28.0M
43.3M
73.9M
-3.20M
36.1M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Skip the spreadsheet. Track your investments automatically.
Start now